Clinical Trial Update: Weight Loss in Parkinson's Disease and Role of Small Bowel Bacterial Overgrowth [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on weight loss in Parkinson's disease and the role of small bowel bacterial overgrowth. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Mayo Clinic | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED | Results posted: 2016-08-04